Rights and permissions
About this article
Cite this article
Oritavancin: favourable efficacy, tolerability in complicated Gram-positive skin/skin-structure infections. Inpharma Wkly. 1392, 7 (2003). https://doi.org/10.2165/00128413-200313920-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313920-00015